Creative Medical Technology Holdings (CELZ) Enterprise Value (2010 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly Enterprise Value of -$5.7 million for Q1 2026, up 26.0% year-over-year from -$4.5 million in Q1 2025, and up 20.82% quarter-over-quarter from -$7.2 million in Q4 2025.
Creative Medical Technology Holdings (CELZ) Enterprise Value (2010 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Enterprise Value for 17 consecutive years, with -$5.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 26.0% year-over-year to -$5.7 million; the TTM figure through Mar 2026 stood at -$5.7 million (up 26.0% YoY), while the FY2025 annual figure was -$7.2 million, down 21.17% from the prior year.
- Enterprise Value rose to -$5.7 million in Q1 2026 per CELZ's latest filing, from -$7.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$3.5 million in Q4 2023 and bottomed at -$22.9 million in Q2 2022.
- Historically, Enterprise Value has averaged -$10.4 million across 5 years, with a median of -$7.7 million in 2025.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 14317.02% — and 2023, when it jumped 81.16%.
- Creative Medical Technology Holdings' Enterprise Value stood at -$18.4 million in 2022, then surged by 81.16% to -$3.5 million in 2023, then sank by 71.35% to -$5.9 million in 2024, then fell by 21.17% to -$7.2 million in 2025, then grew by 20.82% to -$5.7 million in 2026.
- Business Quant data shows CELZ's Enterprise Value at -$5.7 million in Q1 2026, -$7.2 million in Q4 2025, and -$5.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | -8.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.69 Mn |
| Mar 31, 2026 | -5.70 Mn |
| Dec 31, 2025 | -7.20 Mn |
| Sep 30, 2025 | -5.38 Mn |
| Jun 30, 2025 | -6.54 Mn |
| Mar 31, 2025 | -7.70 Mn |
| Dec 31, 2024 | -5.94 Mn |
| Sep 30, 2024 | -6.26 Mn |
| Jun 30, 2024 | -7.47 Mn |
| Mar 31, 2024 | -9.01 Mn |
| Dec 31, 2023 | -3.47 Mn |
| Sep 30, 2023 | -11.97 Mn |
| Jun 30, 2023 | -13.57 Mn |
| Mar 31, 2023 | -14.56 Mn |
| Dec 31, 2022 | -18.40 Mn |
| Sep 30, 2022 | -21.99 Mn |
| Jun 30, 2022 | -22.86 Mn |
| Mar 31, 2022 | -9.15 Mn |
| Dec 31, 2021 | -10.72 Mn |
| Sep 30, 2021 | -2.38 Mn |